| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-06 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-06 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-06 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.24 | 6e-06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.22 | 6e-06 |